Holen Sie sich die Stockscreener-App
3.53
0.57%
0.02
Vorhandelsmarkt:
3.53
Schlusskurs vom Vortag:
$3.51
Offen:
$3.55
24-Stunden-Volumen:
59,247
Relative Volume:
0.12
Marktkapitalisierung:
$56.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-0.1795
EPS:
-19.67
Netto-Cashflow:
$-47.63M
1W Leistung:
+3.22%
1M Leistung:
-2.49%
6M Leistung:
+21.72%
1J Leistung:
-0.56%
1-Tages-Spanne:
$3.45
$3.55
1-Wochen-Bereich:
$3.2614
$3.59
52-Wochen-Spanne:
$2.30
$3.93
Polypid Ltd Stock (PYPD) Company Profile
Vergleichen Sie PYPD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.53 | 54.85M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.76 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.28 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.78 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
656.89 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.51 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-05 | Eingeleitet | Roth Capital | Buy |
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-09-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-07-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-07-21 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-07-21 | Eingeleitet | Barclays | Overweight |
| 2020-07-21 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
Risk adjusted return profile for PolyPid Ltd. analyzedStock Surge & Stock Portfolio Risk Control - Newser
Pattern recognition hints at PolyPid Ltd. upsideJuly 2025 News Drivers & Daily Profit Maximizing Tips - Newser
Does PolyPid Ltd. qualify in momentum factor screeningInflation Watch & Low Risk High Win Rate Stock Picks - Newser
What high frequency data says about PolyPid Ltd.Weekly Risk Summary & Reliable Intraday Trade Alerts - Newser
Does PolyPid Ltd. fit your quant trading modelEarnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Short interest data insights for PolyPid Ltd.Earnings Overview Summary & Advanced Technical Signal Analysis - Newser
Will PolyPid Ltd. benefit from macro trendsWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Can technical indicators confirm PolyPid Ltd.’s reversalGDP Growth & Safe Capital Growth Tips - Newser
What’s the recovery path for long term holders of PolyPid Ltd.2025 Price Targets & Precise Trade Entry Recommendations - Newser
Forecasting PolyPid Ltd. price range with options dataJuly 2025 Earnings & Daily Market Momentum Tracking - Newser
Live market analysis of PolyPid Ltd.Gap Down & Free Real-Time Volume Trigger Notifications - Newser
Will breakout in PolyPid Ltd. lead to full recoveryAnalyst Downgrade & Risk Controlled Daily Plans - Newser
Machine Learning Models Forecast PolyPid Ltd. UptickWeekly Market Report & Risk Controlled Stock Pick Alerts - newsyoung.net
How institutional ownership impacts PolyPid Ltd. stockVolume Spike & Daily Momentum Trading Reports - Newser
Roth Capital Has Negative Outlook for PolyPid Q3 Earnings - Defense World
Detecting price anomalies in PolyPid Ltd. with AIGap Down & Comprehensive Market Scan Insights - Newser
Sector ETF performance correlation with PolyPid Ltd.July 2025 Short Interest & Fast Moving Stock Watchlists - Newser
Can PolyPid Ltd. lead its sector in growthWeekly Earnings Recap & Target Return Focused Picks - classian.co.kr
Is PolyPid Ltd. forming a breakout patternQuarterly Profit Summary & Daily Stock Momentum Reports - classian.co.kr
Custom watchlist performance reports with PolyPid Ltd.2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser
Developing predictive dashboards with PolyPid Ltd. dataMarket Sentiment Review & Long-Term Safe Return Strategies - Newser
PolyPid Ltd. stock volume spike explainedWeekly Market Outlook & Free Weekly Watchlist of Top Performers - Newser
Will PolyPid Ltd. Sustain Its Chart BreakoutJuly 2025 Big Picture & Reliable Price Breakout Signals - newsyoung.net
PolyPid (NASDAQ:PYPD) Rating Lowered to “Sell” at Wall Street Zen - Defense World
HC Wainwright Has Negative Outlook for PolyPid Q3 Earnings - Defense World
PolyPid Ltd. Company Revenue and Profit Trends: A Deep DiveAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why PolyPid Ltd. stock attracts strong analyst attentionSell Signal & Safe Entry Trade Reports - Newser
Is PolyPid Ltd. a candidate for recovery playJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Finanzdaten der Polypid Ltd-Aktie (PYPD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
3.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):